Literature DB >> 18367990

Alarming prevalence of fetal alcohol exposure in a Mediterranean city.

Oscar Garcia-Algar1, Vivan Kulaga, Joey Gareri, Gideon Koren, Oriol Vall, Piergiorgio Zuccaro, Roberta Pacifici, Simona Pichini.   

Abstract

The prevalence of gestational ethanol exposure and subsequent fetal exposure has been assessed in a cohort of mother-infant dyads in a Mediterranean city (Barcelona, Spain) by meconium analysis of fatty acid ethyl esters (FAEEs) after showing in this population a high prevalence of meconium opiates (8.7%), cocaine (4.4%), and cannabis (5.3%). Of the 353 meconium samples analyzed for FAEEs, 159 (45%) contained a total amount of seven FAEEs equal or above 2 nmol/g meconium, the cutoff internationally accepted to differentiate heavy maternal alcohol consumption during pregnancy from occasional use or no use at all. No parental sociodemographic differences or maternal features differentiated exposed from unexposed newborns. The prevalence of gestational consumption of ethanol was similar between women using and not using drugs of abuse during pregnancy (45.7% and 44.7% of samples with total FAEEs equal or higher than 2 nmol/g meconium, respectively). Meconium samples from newborns exposed in utero to ethanol, and positive for at least one illicit drug (cocaine, opiates, or cannabis), had total FAEEs and five of nine individual FAEEs statistically higher than the meconium samples that were negative for the most frequently used illicit drugs of abuse. Among the most prevalent FAEEs, oleic acid ethyl ester showed the best correlation to total FAEE concentration followed by palmitoleic acid ethyl ester . This study, which highlights a 45% ethanol consumption during pregnancy in a low socioeconomic status cohort, may serve as an eye opener for Europeans that gestational alcohol exposure is not endemic only in areas outside of Europe.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18367990     DOI: 10.1097/FTD.0b013e31816a8657

Source DB:  PubMed          Journal:  Ther Drug Monit        ISSN: 0163-4356            Impact factor:   3.681


  13 in total

1.  Head circumference at birth and exposure to tobacco, alcohol and illegal drugs during early pregnancy.

Authors:  Juan A Ortega-García; Jorge E Gutierrez-Churango; Miguel F Sánchez-Sauco; Miguel Martínez-Aroca; Juan L Delgado-Marín; M Sánchez-Solis; J J Parrilla-Paricio; Luz Claudio; Juan F Martínez-Lage
Journal:  Childs Nerv Syst       Date:  2011-10-15       Impact factor: 1.475

2.  Gene expression changes in C57BL/6J and DBA/2J mice following prenatal alcohol exposure.

Authors:  Chris Downing; Stephen Flink; Maria L Florez-McClure; Thomas E Johnson; Boris Tabakoff; Katerina J Kechris
Journal:  Alcohol Clin Exp Res       Date:  2012-04-24       Impact factor: 3.455

Review 3.  Fetal alcohol spectrum disorders: an overview.

Authors:  Edward P Riley; M Alejandra Infante; Kenneth R Warren
Journal:  Neuropsychol Rev       Date:  2011-04-16       Impact factor: 7.444

4.  A utilitarian comparison of two alcohol use biomarkers with self-reported drinking history collected in antenatal clinics.

Authors:  Philip A May; Julie M Hasken; Marlene M De Vries; Anna-Susan Marais; Julie M Stegall; Daniel Marsden; Charles D H Parry; Soraya Seedat; Barbara Tabachnick
Journal:  Reprod Toxicol       Date:  2018-02-06       Impact factor: 3.143

5.  A survey of Italian and Spanish neonatologists and paediatricians regarding awareness of the diagnosis of FAS and FASD and maternal ethanol use during pregnancy.

Authors:  F Vagnarelli; I Palmi; O García-Algar; M Falcon; L Memo; L Tarani; R Spoletini; R Pacifici; C Mortali; A Pierantozzi; S Pichini
Journal:  BMC Pediatr       Date:  2011-06-06       Impact factor: 2.125

6.  Maternal risk factors for fetal alcohol spectrum disorders in a province in Italy.

Authors:  Mauro Ceccanti; Daniela Fiorentino; Giovanna Coriale; Wendy O Kalberg; David Buckley; H Eugene Hoyme; J Phillip Gossage; Luther K Robinson; Melanie Manning; Marina Romeo; Julie M Hasken; Barbara Tabachnick; Jason Blankenship; Philip A May
Journal:  Drug Alcohol Depend       Date:  2014-10-25       Impact factor: 4.492

7.  Prevalence and characteristics of fetal alcohol syndrome and partial fetal alcohol syndrome in a Rocky Mountain Region City.

Authors:  Philip A May; Carol Keaster; Rosemary Bozeman; Joelene Goodover; Jason Blankenship; Wendy O Kalberg; David Buckley; Marita Brooks; Julie Hasken; J Phillip Gossage; Luther K Robinson; Melanie Manning; H Eugene Hoyme
Journal:  Drug Alcohol Depend       Date:  2015-08-14       Impact factor: 4.492

8.  Moderate prenatal alcohol exposure enhances GluN2B containing NMDA receptor binding and ifenprodil sensitivity in rat agranular insular cortex.

Authors:  Clark W Bird; Felicha T Candelaria-Cook; Christy M Magcalas; Suzy Davies; C Fernando Valenzuela; Daniel D Savage; Derek A Hamilton
Journal:  PLoS One       Date:  2015-03-06       Impact factor: 3.240

9.  Alcohol Consumption during Pregnancy: Analysis of Two Direct Metabolites of Ethanol in Meconium.

Authors:  Arantza Sanvisens; Neus Robert; José María Hernández; Paola Zuluaga; Magí Farré; Wifredo Coroleu; Montserrat Serra; Jordi Tor; Robert Muga
Journal:  Int J Mol Sci       Date:  2016-03-22       Impact factor: 5.923

Review 10.  A comparison of the prevalence of prenatal alcohol exposure obtained via maternal self-reports versus meconium testing: a systematic literature review and meta-analysis.

Authors:  Shannon Lange; Kevin Shield; Gideon Koren; Jürgen Rehm; Svetlana Popova
Journal:  BMC Pregnancy Childbirth       Date:  2014-04-03       Impact factor: 3.007

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.